- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Updates, 04-09-2025: General Updates
04-09-2025 | 07:21 pm
04-09-2025 | 07:21 pm
Biocon Biologics' Bengaluru facility faced an FDA inspection, receiving five procedural observations. The company confirms these are minor, not systemic, and expects no impact on commercial product supply. A corrective action plan will be submitted.
No comments yet. Be the first to comment!